Published on New York State Department of Health, Wadsworth Center (https://wadsworth.org)

Northwell Health Cancer Institute at Rego Park a Program of LIJ

Ye Ding, Ph.D.

RNA Bioinformatics

We are engaged in algorithms and software tool development for the prediction of RNA secondary structure and their applications to understand mechanisms of regulatory non-coding RNAs, with a recent focus on microRNAs and small bacterial RNAs.
George Donati

George L. Donati, Ph.D.

Deputy Director - Laboratory of Inorganic and Nuclear Chemistry

We develop new approaches to calibration and use advanced statistical tools to minimize matrix effects and improve the accuracy and sample throughput of spectrochemical methods such as MIP-OES, ICP-OES, and ICP-MS to determine trace elements in a wide variety of samples of public health interest.

Christina Egan, Ph.D.

Deputy Director, Division of Infectious Diseases

We focus on the development and validation of assays to detect pathogens and toxins associated with bioterrorism or food-borne disease. We utilize methods such as real-time PCR, whole genome sequencing, and mass spectrometry for rapid detection of agents.

Vincent Escuyer, Ph.D.

Director, Mycobacteriology Laboratory

We are interested in the mechanisms underlying resistance of M. tuberculosis to major TB drugs and in the development and validation of molecular assays involving whole genome sequencing for rapid detection of drug resistant tuberculosis.

Pallavi Ghosh, Ph.D.

Mycobacterial Stress Response

We study transcriptional reprogramming and regulatory networks in mycobacteria controlling resistance to genotoxic stress, hypoxia, nutrient starvation and exposure to antibiotics.
Robert L. Glaser

Robert L. Glaser, Ph.D.

Director, Division of Laboratory Operations

The Division of Laboratory Operations oversees the Wadsworth Center's operations at five facilities in the Albany area, totaling ~900,000 square feet of space and over 210 acres of real estate.

Todd Gray, Ph.D.

Molecular Genetics of Mycobacteria

We use innovative molecular genomic approaches to address fundamental questions of mycobacterial biology. Our findings shed new light on the evolution and function of mycobacterial genomes, accelerating tuberculosis research.

Bruce J. Herron, Ph.D.

Mammalian Genomics

We utilize an array of mammalian genomic tools to discover genetic modifiers that influence multifactorial diseases. These susceptibility loci are targets for diagnosis and treatment of similar disorders in humans.

Kurunthachalam Kannan, Ph.D.

Deputy Director of the Division of Environmental Health Sciences

Biomonitoring of human exposure to environmental chemicals; biomarkers of health effects; sources and pathways of human exposure; environmental distribution, food chain transfer and fate of organic pollutants; consumer product analysis; overdose and wastewater surveillance

Denise M. Kay, Ph.D.

Newborn Screening Program

We use targeted and genome-wide approaches to identify and characterize mutations/genes involved in diseases affecting children, including conditions screened by the NYS newborn screening program and birth defects.

Alexey Khodjakov, Ph.D.

Cellular and Molecular Basis of Diseases - Mitosis

We seek to reveal the molecular mechanisms that enact error-free segregation of chromosomes during cell division. Advanced microscopy and laser ablations allow us to probe the behavior of individual chromosomes and spindle poles.

Haider A. Khwaja, Ph.D.

Environmental Atmospheric Chemistry Laboratory

We conduct multidisciplinary research to understand water and indoor and outdoor air pollution and their impact on human health.

Kerri Kluetzman, Ph.D.

Research Scientist

The Transgenic and Gene Knockout Core produces and analyzes transgenic and gene knockout mice that can be used as animal models of human disease.

Pascal Lapierre, Ph.D.

Bioinformatics and Statistics Core

My specific area of expertise within the Bioinformatics Core is bacterial genomics, evolution and phylogeny.

David A. Lawrence, Ph.D.

Neuroimmunology and Immunotoxicology

We study the immunological aspect of the system biology effects from genetic susceptibilities and environmental stress defined as the exposome on autoimmune diseases, immune deficiencies, and neurodegenerative and neurobehavioral illnesses.